GPC3 expression is down regulated in lung adenocarcinoma and clear cell renal carcinoma [ 34- 35] but overexpression occurs in hepatocellular carcinoma, ovarian clear cell carcinoma, melanoma, and neuroblastoma [ 14, 24, 36- 37]. This evidence concerns the gene GPC3 and ovarian clear cell cancer.